Latest news
Search news stories
Enter a keyword to search news.
ENZAMET shows promise as prostate cancer treatment
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI) that operates within the ÐÓ°ÉÖ±²¥ of Adelaide, have been published today in .
[Read more about ENZAMET shows promise as prostate cancer treatment ]
Top talent to boost cancer research
The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI).Â
![RSS News Feed](/global/images/rss.gif" "RSS News Feed"){kind=small}